Literature DB >> 7550740

Electroporation of mycobacteria.

T Parish1, N G Stoker.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7550740     DOI： 10.1385/0-89603-310-4:237

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  4 in total

1.  Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection.

Authors:  I Bontempi; K Leal; E Prochetto; G Díaz; G Cabrera; A Bortolotti; H R Morbidoni; S Borsuk; O Dellagostin; I Marcipar
Journal:  Clin Exp Immunol       Date:  2020-07-06       Impact factor: 4.330

2.  Identification and recombinant expression of a Mycobacterium avium rhamnosyltransferase gene (rtfA) involved in glycopeptidolipid biosynthesis.

Authors:  T M Eckstein; F S Silbaq; D Chatterjee; N J Kelly; P J Brennan; J T Belisle
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

3.  Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.

Authors:  Paula B Varaldo; Luciana C C Leite; Waldely O Dias; Eliane N Miyaji; Fabio I G Torres; Vera C Gebara; Geraldo R G Armôa; Adriano S Campos; Denise C S Matos; Nathalie Winter; Brigitte Gicquel; Mônica M Vilar; Johnjoe McFadden; Marilia S Almeida; Miriam Tendler; Douglas McIntosh
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

4.  Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin.

Authors:  Caroline Rizzi; Ana Carolina Peiter; Thaís Larré Oliveira; Amilton Clair Pinto Seixas; Karen Silva Leal; Daiane Drawanz Hartwig; Fabiana Kommling Seixas; Sibele Borsuk; Odir Antônio Dellagostin
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-02       Impact factor: 2.743
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.